Beatriz Ospina

发表

Glutaminase is essential for the growth of triple-negative breast cancer cells with a deregulated glutamine metabolism pathway and its suppression synergizes with mTOR inhibition

D. Wiederschain, C. Winter, J. Pollard, 2017, PloS one.

A trispecific antibody targeting HER2 and T cells inhibits breast cancer growth via CD4 cells

G. Nabel, D. Wiederschain, Huawei Qiu, 2022, Nature.

HIF2alpha cooperates with RAS to promote lung tumorigenesis in mice.

D. Hayes, Kwok-Kin Wong, W. Kaelin, 2009, The Journal of clinical investigation.

sensitivity to therapy cells with the bone marrow microenvironment and enhances their CXCR 4 inhibitor AMD 3100 disrupts the interaction of multiple myeloma

Charles P. Lin, B. Rollins, N. Munshi, 2009 .

Discovery of Selective, Covalent FGFR4 Inhibitors with Antitumor Activity in Models of Hepatocellular Carcinoma.

J. McDonald, Beatriz Ospina, J. Murtie, 2020, ACS medicinal chemistry letters.

Inhibition of tumorigenesis driven by different Wnt proteins requires blockade of distinct ligand-binding regions by LRP6 antibodies

R. Mosher, W. Sellers, P. Finan, 2010, Proceedings of the National Academy of Sciences.

Interfering with Resistance to Smoothened Antagonists by Inhibition of the PI3K Pathway in Medulloblastoma

Jing Yuan, William R. Sellers, Christoph Lengauer, 2010, Science Translational Medicine.

Amendment history : Corrigendum ( October 2009 ) HIF 2 a cooperates with RAS to promote lung tumorigenesis in mice

D. Hayes, Kwok-Kin Wong, W. Kaelin, 2018 .

HIF2α cooperates with RAS to promote lung tumorigenesis in mice (Journal of Clinical Investigation (2009) 119, (2160-2170) doi:101172/JCI38443)

D. Hayes, Kwok-Kin Wong, W. Kaelin, 2009 .

Trispecific antibodies enhance the therapeutic efficacy of tumor-directed T cells through T cell receptor co-stimulation

G. Nabel, M. Chiron, Huawei Qiu, 2019, Nature Cancer.

CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy.

Charles P. Lin, B. Rollins, N. Munshi, 2009, Blood.

In Vivo Mobilization of Multiple Myeloma Cells Out of the Bone Marrow Using the CXCR4 Inhibitor AMD3100 and Bortezomib: Implications for Sensitization of Myeloma Cells to Apoptosis.

Charles P. Lin, A. Kung, C. Pitsillides, 2007 .

Interfering with Resistance to Smoothened Antagonists by Inhibition of the PI3K Pathway in Medulloblastoma

Michael P. Morrissey, W. Sellers, J. Monahan, 2010, Science Translational Medicine.